PFE Financial Facts
Income from continuing operations: 1.32BDiscontinued operations--net of tax: 0
See Full Income Statement
Short-term investments: 12.28B
Total liabilities: 114.83B
See Full Balance Sheet
Pfizer Inc. (PFE) Earnings
|
Expand Research on PFE
| Next EPS Date | 7/28/22 *Est. | EPS Growth Rate | +74.2% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +17.8% | Revenue Growth Rate | +76.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +3.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/3/22 |  |
Q122 | $1.62 | $1.47 | +$0.15 | $25.7B | $23.86B |  |
 | | Details |
| 2/8/22 | |
Q421 | $1.08 | $0.88 | +$0.20 | $23.8B | $24.17B | |
| | Details |
| 11/2/21 | |
Q321 | $1.37 | $1.08 | +$0.29 | $24.1B | $22.68B |  |
| | Details |
| 7/28/21 | |
Q221 | $1.07 | $0.96 | +$0.11 | $19B | $18.45B | |
| | Details |
| 5/4/21 | |
Q121 | $0.93 | $0.78 | +$0.15 | $14.6B | $13.6B | |
| | Details |
| 2/2/21 | |
Q420 | $0.42 | $0.48 | -$0.06 | $11.7B | $11.43B | |
| | Details |
| 10/27/20 | |
Q320 | $0.72 | $0.71 | +$0.01 | $12.1B | $12.33B | = | | | Details |
| 7/28/20 | |
Q220 | $0.78 | $0.66 | +$0.12 | $11.8B | $11.55B | = | | | Details |
